A Single dose, Open-Label, Randomized, 2-Way Crossover Bioequivalence Study of Ulipristal Acetate 30 mg Tablets Manufactured at LEON Farma (Spain) and Cardinal Health France (France) Under Fasted Conditions in Healthy Female Volunteers.

Trial Profile

A Single dose, Open-Label, Randomized, 2-Way Crossover Bioequivalence Study of Ulipristal Acetate 30 mg Tablets Manufactured at LEON Farma (Spain) and Cardinal Health France (France) Under Fasted Conditions in Healthy Female Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Ulipristal (Primary)
  • Indications Pregnancy; Uterine leiomyoma
  • Focus Pharmacokinetics
  • Sponsors HRA Pharma
  • Most Recent Events

    • 09 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top